Superbug secrets: can genes make a Last-Resort drug fail?
NCT ID NCT07475429
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether certain genes in a dangerous superbug (carbapenem-resistant hypervirulent Klebsiella pneumoniae) make it resistant to the powerful antibiotic cefiderocol. Researchers will collect samples from 100 infected patients and test the bacteria in the lab. The goal is to understand why some superbugs survive this last-resort drug, which could help doctors choose better treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARBAPENEM-RESISTANT HYPERVIRULENT KLEBSIELLA PNEUMONIAE INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Faculty of Medicine
Sohag, Egypt